| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REGENERX BIOPHARMACEUTICALS INC | Director | Common Stock | 6,524,122 | 17 May 2022 | Direct | ||
| REGENERX BIOPHARMACEUTICALS INC | Director | Stock Option (Right to Buy) | 290,000 | 17 May 2022 | Direct | ||
| REGENERX BIOPHARMACEUTICALS INC | Director | Convertible Promissory Note (right to buy) | 78,125 | 17 May 2022 | Direct | ||
| REGENERX BIOPHARMACEUTICALS INC | Director | Common Stock Warrant (right to buy) | 0 | 17 May 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000143774922013085-mcnay-joseph-c-2022-05-17 | REGENERX BIOPHARMACEUTICALS INC | 17 May 2022 | 1 | $0 | 4 | Director | 19 May 2022, 17:04 |
| /report/000091419021000207-mcnay-joseph-c-2021-08-02 | REGENERX BIOPHARMACEUTICALS INC | 02 Aug 2021 | 1 | $0 | 4 | Director | 04 Aug 2021, 16:14 |